Hainan Sea Medicine 122 million set up bio-pharmaceutical industry venture capital Fund

Hainan Sea Medicine (000566) March 4 Evening announcement, the company intends to work with the surplus rich Tai Venture Investment Co., Ltd., Haikou Innovation Industry Investment Co., Ltd., Hainan Bang International Industrial Co., Ltd., Hainan Atlas Equity Investment Fund Management Co., Ltd., Chongqing Jie Sheng Investment Co., Ltd. and other partners launched the establishment of Hainan Atlas Bio-pharmaceutical Industry venture Capital Partnership (limited Partnership), the company as a limited partner investment 122 million yuan, accounting for the 48.8% equity venture capital. Hainan Atlas Bio-pharmaceutical Industry venture Capital Partnership (limited Partnership) business scope for the biological and new pharmaceutical technology and innovative applications and other areas of entrepreneurial investment, venture capital consulting business, to provide entrepreneurial business management services. The amount of funds invested by the fund is 250 million yuan. The company says the pharmaceutical industry will remain growing, at the same time, there are more good equity investment opportunities in the industry, Atlas Venture Capital will pay attention to the core competitiveness of the bio-and new pharmaceutical growth enterprises, to biological and new pharmaceutical technology and innovative applications as the main investment areas, in the early middle stage of the enterprise as the main investment object, For enterprises to graft resources, and entrepreneurs to share the growth experience, for the fund investors to create returns.